Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
$0.56
+0.0%
$0.61
$0.46
$1.72
$29.35M1.3191,233 shs23,453 shs
inTEST Co. stock logo
INTT
inTEST
$7.28
-1.6%
$6.42
$5.24
$11.92
$90.96M1.6253,253 shs13,135 shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$0.72
+4.5%
$0.74
$0.66
$3.09
$87.51M1.44157,696 shs539,609 shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$8.52
+0.4%
$7.33
$3.09
$11.99
$103.62M0.1622,324 shs59,239 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
+0.02%-2.93%-16.31%-26.34%-32.89%
inTEST Co. stock logo
INTT
inTEST
-1.62%+5.20%+20.33%+6.28%-26.32%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
+4.50%+4.29%-2.71%-12.67%-69.02%
Prenetics Global Limited stock logo
PRE
Prenetics Global
+0.35%+4.80%-10.32%+120.73%+43.92%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
2.273 of 5 stars
3.53.00.00.02.60.00.6
inTEST Co. stock logo
INTT
inTEST
3.4496 of 5 stars
3.33.00.00.02.73.31.3
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.4397 of 5 stars
2.52.00.00.03.04.20.6
Prenetics Global Limited stock logo
PRE
Prenetics Global
1.2007 of 5 stars
1.54.00.00.02.20.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
3.00
Buy$2.00257.21% Upside
inTEST Co. stock logo
INTT
inTEST
2.67
Moderate Buy$12.0064.84% Upside
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
1.00
Sell$2.13193.14% Upside
Prenetics Global Limited stock logo
PRE
Prenetics Global
3.00
Buy$9.005.63% Upside

Current Analyst Ratings Breakdown

Latest CLIR, PRE, NAUT, and INTT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2025
inTEST Co. stock logo
INTT
inTEST
Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/5/2025
inTEST Co. stock logo
INTT
inTEST
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $8.00
4/17/2025
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.00 ➝ $2.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
$3.60M8.15N/AN/A$0.27 per share2.07
inTEST Co. stock logo
INTT
inTEST
$127.50M0.71$1.27 per share5.75$7.92 per share0.92
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.66 per shareN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
$30.62M3.39N/AN/A$14.04 per share0.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
-$5.30M-$0.12N/A55.99N/A-216.48%-44.36%-38.35%8/18/2025 (Estimated)
inTEST Co. stock logo
INTT
inTEST
$9.34M-$0.0131.6518.20N/A2.33%5.31%3.42%N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/A

Latest CLIR, PRE, NAUT, and INTT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14N/AN/AN/AN/AN/A
6/12/2025Q1 2025
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A-$0.80N/A-$0.80N/A$17.31 million
5/2/2025Q1
inTEST Co. stock logo
INTT
inTEST
-$0.10-$0.11-$0.01N/AN/AN/A
4/29/2025Q1 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14-$0.13+$0.01-$0.13N/AN/A
4/2/2025Q4 2024
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
-$0.03-$0.02+$0.01-$0.02$1.55 million$0.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
N/AN/AN/AN/AN/A
inTEST Co. stock logo
INTT
inTEST
N/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
N/A
5.63
5.63
inTEST Co. stock logo
INTT
inTEST
0.08
2.26
1.38
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
17.36
17.36
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
2.07
1.89

Institutional Ownership

CompanyInstitutional Ownership
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
24.03%
inTEST Co. stock logo
INTT
inTEST
63.18%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Prenetics Global Limited stock logo
PRE
Prenetics Global
25.01%

Insider Ownership

CompanyInsider Ownership
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
4.96%
inTEST Co. stock logo
INTT
inTEST
7.00%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
41.10%
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearSign Technologies Corporation stock logo
CLIR
ClearSign Technologies
1052.42 million49.82 millionOptionable
inTEST Co. stock logo
INTT
inTEST
32012.50 million11.69 millionOptionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130126.15 million74.30 millionOptionable
Prenetics Global Limited stock logo
PRE
Prenetics Global
112.20 millionN/ANot Optionable

Recent News About These Companies

Prenetics Global Limited (PRE) - Yahoo Finance
Prenetics Adopts $20M Bitcoin Treasury Strategy
Brokers Set Expectations for PRE FY2026 Earnings
Prenetics Global reports Q1 2025 financials

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ClearSign Technologies stock logo

ClearSign Technologies NASDAQ:CLIR

$0.56 +0.00 (+0.02%)
As of 06/30/2025 03:59 PM Eastern

ClearSign Technologies Corporation designs and develops products and technologies to enhance emission and operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States, the People's Republic of China, and Hong Kong. The company's technologies include ClearSign core burner technology consists of an industrial burner body and a downstream porous ceramic or metal flame stabilizing structure; ClearSign core process burner technology that provides a direct burner replacement for traditional refinery process heaters; ClearSign core boiler burner technology; ClearSign core flaring burners that can be used individually, or in combination, to provide a flare product with extremely low nitrogen oxide emissions; and ClearSign eye flame sensor, an electrical flame sensor for industrial applications. It serves energy, institutional, commercial and industrial boiler, chemical, and petrochemical industries. The company was formerly known as ClearSign Combustion Corporation and changed its name ClearSign Technologies Corporation in November 2019. ClearSign Technologies Corporation was incorporated in 2008 and is headquartered in Tulsa, Oklahoma.

inTEST stock logo

inTEST NYSE:INTT

$7.28 -0.12 (-1.62%)
As of 06/30/2025 04:00 PM Eastern

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$0.72 +0.03 (+4.50%)
As of 06/30/2025 04:00 PM Eastern

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Prenetics Global stock logo

Prenetics Global NASDAQ:PRE

$8.52 +0.03 (+0.35%)
As of 06/30/2025 03:59 PM Eastern

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.